APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchChemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs include Baxter, Helsinn, Heron Therapeutics, Mundipharma, Sun Pharma, GSK, Haisco, Roche and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Company

Baxter

Helsinn

Heron Therapeutics

Mundipharma

Sun Pharma

GSK

Haisco

Roche

Mylan

Merck

Novartis

Qilu Pharma

Teva

Eisai

Southwest Pharma

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type

5-HT3 Inhibitors

NK1 Inhibitors

Others

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application

Acute CINV

Breakthrough CINV

Delayed CINV

Others

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends Table 2. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Drivers Table 3. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Opportunities and Challenges Table 4. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Restraints Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers Table 9. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers, Product Type & Application Table 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5-HT3 Inhibitors Table 17. Major Manufacturers of NK1 Inhibitors Table 18. Major Manufacturers of Others Table 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units) Table 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2027-2032) & (M Units) Table 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2021-2026) Table 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2027-2032) Table 24. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 25. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2021-2026) & (M Units) Table 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2027-2032) & (M Units) Table 27. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Acute CINV Table 30. Major Manufacturers of Breakthrough CINV Table 31. Major Manufacturers of Delayed CINV Table 32. Major Manufacturers of Others Table 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 34. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units) Table 35. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2027-2032) & (M Units) Table 36. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2021-2026) Table 37. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2027-2032) Table 38. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 39. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2021-2026) & (M Units) Table 40. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2027-2032) & (M Units) Table 41. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 44. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021-2026) & (M Units) Table 45. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2021-2026) Table 46. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecasted by Region (2027-2032) & (M Units) Table 47. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 49. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units) Table 50. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2027-2032) & (M Units) Table 51. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 52. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units) Table 53. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2027-2032) & (M Units) Table 54. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units) Table 56. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2027-2032) & (M Units) Table 57. South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 58. South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units) Table 59. South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2027-2032) & (M Units) Table 60. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2027-2032) Table 65. Baxter Company Information Table 66. Baxter Business Overview Table 67. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 69. Baxter Recent Development Table 70. Helsinn Company Information Table 71. Helsinn Business Overview Table 72. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 74. Helsinn Recent Development Table 75. Heron Therapeutics Company Information Table 76. Heron Therapeutics Business Overview Table 77. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 79. Heron Therapeutics Recent Development Table 80. Mundipharma Company Information Table 81. Mundipharma Business Overview Table 82. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 84. Mundipharma Recent Development Table 85. Sun Pharma Company Information Table 86. Sun Pharma Business Overview Table 87. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 89. Sun Pharma Recent Development Table 90. GSK Company Information Table 91. GSK Business Overview Table 92. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 94. GSK Recent Development Table 95. Haisco Company Information Table 96. Haisco Business Overview Table 97. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 99. Haisco Recent Development Table 100. Roche Company Information Table 101. Roche Business Overview Table 102. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 104. Roche Recent Development Table 105. Mylan Company Information Table 106. Mylan Business Overview Table 107. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 109. Mylan Recent Development Table 110. Merck Company Information Table 111. Merck Business Overview Table 112. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 114. Merck Recent Development Table 115. Novartis Company Information Table 116. Novartis Business Overview Table 117. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 119. Novartis Recent Development Table 120. Qilu Pharma Company Information Table 121. Qilu Pharma Business Overview Table 122. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 124. Qilu Pharma Recent Development Table 125. Teva Company Information Table 126. Teva Business Overview Table 127. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 129. Teva Recent Development Table 130. Eisai Company Information Table 131. Eisai Business Overview Table 132. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 134. Eisai Recent Development Table 135. Southwest Pharma Company Information Table 136. Southwest Pharma Business Overview Table 137. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio Table 139. Southwest Pharma Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List Table 143. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Image Figure 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (2021-2032) & (M Units) Figure 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5-HT3 Inhibitors Image Figure 9. NK1 Inhibitors Image Figure 10. Others Image Figure 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2021-2032) Figure 17. Acute CINV Image Figure 18. Breakthrough CINV Image Figure 19. Delayed CINV Image Figure 20. Others Image Figure 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 25. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 28. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 32. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 33. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 35. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 36. U.K. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Netherlands Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021-2032) Figure 41. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 43. South Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 45. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 46. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 50. South Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 54. UAE Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Egypt Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Chile Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 5-HT3 Inhibitors
  • NK1 Inhibitors
  • Others
Applications
  • Acute CINV
  • Breakthrough CINV
  • Delayed CINV
  • Others
Companies covered
  • Baxter
  • Helsinn
  • Heron Therapeutics
  • Mundipharma
  • Sun Pharma
  • GSK
  • Haisco
  • Roche
  • Mylan
  • Merck
  • Novartis
  • Qilu Pharma
  • Teva
  • Eisai
  • Southwest Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Dynamics
  1. 2.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
  2. 2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Drivers
  3. 2.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Opportunities and Challenges
  4. 2.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Restraints
3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market by Manufacturers
  1. 3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Tier 1, Tier 2, and Tier 3
4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market by Type
  1. 4.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Type Introduction
  2. 4.1.1 5-HT3 Inhibitors
  3. 4.1.2 NK1 Inhibitors
  4. 4.1.3 Others
  5. 4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
  6. 4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type
  10. 4.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2021-2032)
5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market by Application
  1. 5.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Application Introduction
  2. 5.1.1 Acute CINV
  3. 5.1.2 Breakthrough CINV
  4. 5.1.3 Delayed CINV
  5. 5.1.4 Others
  6. 5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
  7. 5.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application
  11. 5.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2021-2032)
6 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
  1. 6.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region
  1. 7.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region
  2. 7.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2021-2032)
  8. 7.2.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter
  2. 8.1.1 Baxter Company Information
  3. 8.1.2 Baxter Business Overview
  4. 8.1.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  6. 8.1.5 Baxter Recent Developments
  7. 8.2 Helsinn
  8. 8.2.1 Helsinn Company Information
  9. 8.2.2 Helsinn Business Overview
  10. 8.2.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  12. 8.2.5 Helsinn Recent Developments
  13. 8.3 Heron Therapeutics
  14. 8.3.1 Heron Therapeutics Company Information
  15. 8.3.2 Heron Therapeutics Business Overview
  16. 8.3.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  18. 8.3.5 Heron Therapeutics Recent Developments
  19. 8.4 Mundipharma
  20. 8.4.1 Mundipharma Company Information
  21. 8.4.2 Mundipharma Business Overview
  22. 8.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  24. 8.4.5 Mundipharma Recent Developments
  25. 8.5 Sun Pharma
  26. 8.5.1 Sun Pharma Company Information
  27. 8.5.2 Sun Pharma Business Overview
  28. 8.5.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  30. 8.5.5 Sun Pharma Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Haisco
  38. 8.7.1 Haisco Company Information
  39. 8.7.2 Haisco Business Overview
  40. 8.7.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  42. 8.7.5 Haisco Recent Developments
  43. 8.8 Roche
  44. 8.8.1 Roche Company Information
  45. 8.8.2 Roche Business Overview
  46. 8.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  48. 8.8.5 Roche Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Merck
  56. 8.10.1 Merck Company Information
  57. 8.10.2 Merck Business Overview
  58. 8.10.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  60. 8.10.5 Merck Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 Qilu Pharma
  68. 8.12.1 Qilu Pharma Company Information
  69. 8.12.2 Qilu Pharma Business Overview
  70. 8.12.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  72. 8.12.5 Qilu Pharma Recent Developments
  73. 8.13 Teva
  74. 8.13.1 Teva Company Information
  75. 8.13.2 Teva Business Overview
  76. 8.13.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  78. 8.13.5 Teva Recent Developments
  79. 8.14 Eisai
  80. 8.14.1 Eisai Company Information
  81. 8.14.2 Eisai Business Overview
  82. 8.14.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  84. 8.14.5 Eisai Recent Developments
  85. 8.15 Southwest Pharma
  86. 8.15.1 Southwest Pharma Company Information
  87. 8.15.2 Southwest Pharma Business Overview
  88. 8.15.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
  90. 8.15.5 Southwest Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Value Chain Analysis
  2. 9.1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Mode & Process
  6. 9.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors
  9. 9.2.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst